| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Menorrhagia | 3 | 1 | |
| Adenomyosis | 1 | 0 | |
| Endometriosis | 1 | 0 | |
| Menstrual spotting | 1 | 0 | |
| Uterine tumor | 1 | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 1 |
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Menorrhagia | 3 | 1 | |
| Adenomyosis | 1 | 0 | |
| Endometriosis | 1 | 0 | |
| Menstrual spotting | 1 | 0 | |
| Uterine tumor | 1 | 1 |
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 1 |